findmyKOL

Julia Dombrowski, MD

Basic profile

Public Health

ORCID↗NPI↗
✓ Full record
RegionSeattle, WA · WestSpecialtyInfectious DiseaseFocusInfectious Disease
Active KOLfindmyKOL type: RegionalLatest publication2025Online presenceNot yet checkedPaymentsNone reportedNIH funding2010–2026Why? →

Julia Dombrowski is an Infectious Disease physician affiliated with Public Health. OpenAlex indexes 200 publications with 4,679 citations (h-index 37).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
200publications

Distinct works indexed by OpenAlex, matched via ORCID.

4,679citations

Total citations across indexed works.

37h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
6NIH grants · 2010–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

325 9th Ave
Box 359777
Seattle, WA 981042420

Telephone

206-744-5640

Registry record last updated 8 Feb 2012.

View the NPPES registry record

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    32.5%
    Gabapentinoids6.4%
    Gabapentin86%Pregabalin14%
    Part D<11 patients
    Opioid Agonist5.7%
    Oxycodone Hcl75%Oxycodone-Acetaminophen25%
    Part D<11 patients

    + 10 more classes in this area

  • Anti-infectives

    29.7%
    Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor12.2%
    Tivicay63%Juluca31%Isentress6%
    Part D<11 patients
    Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor10.7%
    Descovy80%Emtricitabine-Tenofovir Disop12%Triumeq8%
    Part D<11 patients

    + 5 more classes in this area

  • Cardiovascular

    15.3%
    Statin5.9%
    Atorvastatin Calcium52%Rosuvastatin Calcium48%
    Part D<11 patients
    ACE inhibitor4.3%
    Lisinopril100%
    Part D≥13 patients

    + 2 more classes in this area

Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

6 NIH research awards on record, funded 2010–2026 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”